Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance

World Journal of Gastroenterology

Volumn 17, Issue 35, 2011, Pages 3986-3993

  Wang, Ji Heng ^a   Du, Jing Ping ^a   Zhang, Ying Hai ^b   Zhao, Xiao Jun ^a   Fan, Ru Ying ^a   Wang, Zhi Hong ^a   Wu, Zi Tao ^a   Han, Ying ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Apoptosis; Chemotherapy; Drug resistance; Gastric cancer; Prion protein

Indexed keywords

DOXORUBICIN; PRION PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN EXPRESSION; STOMACH CANCER; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 80054860599     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i35.3986     Document Type: Article

References (30)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144
2. Du JP, Jin XH, Shi YQ, Zhao YQ, Liu CJ, Cao YX, Qiao TD, Chen BJ, Fan DM. [The over-expression of prion protein in drug resistant gastric cancer cell line SGC7901/ADR and its significance]. Zhonghua YiXue ZaZhi 2003; 83: 328-332
3. Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T, Fan D. Over-expression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113: 213-220
4. Liang J, Ge F, Guo C, Luo G, Wang X, Han G, Zhang D, Wang J, Li K, Pan Y, Yao L, Yin Z, Guo X, Wu K, Ding J, Fan D. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS J 2009; 276: 685-694
5. Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu N, Zhang G, Jin H, Gao J, Xie H, Wang J, Liu Z, Fan D. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20: 1886-1888
6. Liang J, Pan YL, Ning XX, Sun LJ, Lan M, Hong L, Du JP, Liu N, Liu CJ, Qiao TD, Fan DM. Over-expression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol 2006; 27: 84-91
7. Liang J, Wang JB, Pan YL, Wang J, Liu LL, Guo XY, Sun L, Lin T, Han S, Xie HH, Yin F, Guo XG, Fan D. High frequency occurrence of 1-OPRD variant of PRNP gene in gastric cancer cell lines and Chinese population with gastric cancer. Cell Biol Int 2006; 30: 920-923
8. Liang J, Bai F, Luo G, Wang J, Liu J, Ge F, Pan Y, Yao L, Du R, Li X, Fan R, Zhang H, Guo X, Wu K, Fan D. Hypoxia induced over-expression of PrP(C) in gastric cancer cell lines. Cancer Biol Ther 2007; 6: 769-774
9. Liang J, Pan Y, Zhang D, Guo C, Shi Y, Wang J, Chen Y, Wang X, Liu J, Guo X, Chen Z, Qiao T, Fan D. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 2007; 21: 2247-2256
10. Du JP, Chen P, Fei HX, Yang MH, Chen ZH. Establishment of adriamyciniamycin-resistant and cisplatin-resistant gastric carcinoma cell lines and assessment on their sustainability of drug resistance. Chin J Gastroenterol Hepatol 2007; 4: 368-372
11. Liang J, Wang J, Luo G, Pan Y, Wang X, Guo C, Zhang D, Yin F, Zhang X, Liu J, Wang J, Guo X, Wu K, Fan D. Function of PrPC (1-OPRD) in biological activities of gastric cancer cell lines. J Cell Mol Med 2009; 13: 4453-4464
12. Liang J, Luo G, Ning X, Shi Y, Zhai H, Sun S, Jin H, Liu Z, Zhang F, Lu Y, Zhao Y, Chen X, Zhang H, Guo X, Wu K, Fan D. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol 2007; 85: 375-383
13. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, Fan D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185: 211-218
14. Ramljak S, Asif AR, Armstrong VW, Wrede A, Groschup MH, Buschmann A, Schulz-Schaeffer W, Bodemer W, Zerr I. Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. J Proteome Res 2008; 7: 2681-2695
15. Bainbridge J, Walker KB. The normal cellular form of prion protein modulates T cell responses. Immunol Lett 2005; 96: 147-150
16. Massimino ML, Ferrari J, Sorgato MC, Bertoli A. Heterogeneous PrPC metabolism in skeletal muscle cells. FEBS Lett 2006; 580: 878-884
17. Shmakov AN, Bode J, Kilshaw PJ, Ghosh S. Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins? J Pathol 2000; 191: 318-322
18. Diarra-Mehrpour M, Arrabal S, Jalil A, Pinson X, Gaudin C, Piétu G, Pitaval A, Ripoche H, Eloit M, Dormont D, Chouaib S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res 2004; 64: 719-727
19. Pammer J, Cross HS, Frobert Y, Tschachler E, Oberhuber G. The pattern of prion-related protein expression in the gastrointestinal tract. Virchows Arch 2000; 436: 466-472
20. Lima FR, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 2007; 103: 2164-2176
21. Mehrpour M, Codogno P. Prion protein: From physiology to cancer biology. Cancer Lett 2010; 290: 1-23
22. Meslin F, Hamaï A, Gao P, Jalil A, Cahuzac N, Chouaib S, Mehrpour M. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res 2007; 67: 10910-10919
23. Kurschner C, Morgan JI. Analysis of interaction sites in homo-and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 1996; 37: 249-258
24. Demeule M, Jodoin J, Gingras D, Béliveau R. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett 2000; 466: 219-224
25. Meslin F, Conforti R, Mazouni C, Morel N, Tomasic G, Drusch F, Yacoub M, Sabourin JC, Grassi J, Delaloge S, Mathieu MC, Chouaib S, Andre F, Mehrpour M. Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol 2007; 18: 1793-1798
26. Sisó S, Puig B, Varea R, Vidal E, Acín C, Prinz M, Montrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol 2002; 103: 615-626
27. Park SK, Choi SI, Jin JK, Choi EK, Kim JI, Carp RI, Kim YS. Differential expression of Bax and Bcl-2 in the brains of hamsters infected with 263K scrapie agent. Neuroreport 2000; 11: 1677-1682
28. Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ 2005; 12: 783-795
29. Kim BH, Lee HG, Choi JK, Kim JI, Choi EK, Carp RI, Kim YS. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res 2004; 124: 40-50
30. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, Kodama T, Aburatani H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002; 62: 233-240